Abstract
The aim of this study was to evaluate the sensitivity and usefulness of high resolution ultrasonography (US) and dual phase technetium-99m sestamibi (Tc-MIBI) scintigraphy in the preoperative localization of parathyroid lesions in patients with or without thyroid disease and to define the impact of the presence of thyroid disease on these methods. Preoperative US and scintigraphy were performed on 52 patients with primary hyperparathyroidism. Age, gender, preoperative parathyroid hormone level, serum calcium level, serum phosphate level, diameter, location, associated with thyroid abnormality, and results of parathyroid exploration were determined in all patients. The results of US and Tc-MIBI imaging were analyzed and compared with surgical and histopathologic findings. At surgery, 56 parathyroid lesions were found in 52 patients (9 men, 43 women), the parathyroid lesion was solitary (47 adenomas, two hyperplasias), in 2 patients double adenomas were present, in 1 patient three glands was affected by hyperplasia. Twenty-seven patients had concomitant thyroid disease. The overall sensitivity of US and Tc-MIBI scintigraphy was 84% and 73%, respectively. In patients without thyroid disease, the sensitivity of these techniques was 90% and 75%, respectively. In patients with thyroid disease, the sensitivity was 78% and 70%, respectively. In patients with thyroid disease, the combined sensitivity of these techniques was 89%. These results allow the conclusion that, in experienced hands, US is a highly sensitive technique. Especially in patients with no thyroid pathology and typical located gland, US alone should be used as a first step for preoperative localization of parathyroid lesions. When negative, Tc-MIBI scintigraphy is suggested. In patients with concomitant thyroid disease, the combination of US and Tc-MIBI scintigraphy represents a reliable localization technique.
Similar content being viewed by others
References
Heath H 3rd. Primary hyperparathyroidism: recent advances in pathogenesis, diagnosis, and management. Adv Intern Med 1992, 37: 275–93.
Heath H, Hodgson SF, Kennedy MA. Primary hyperparathyroidism: incidence, morbidity and potential economic impact in a community. N Engl J Med 1980, 203: 189–93.
Rudberg C, Akerstrom G, Palmer M, et al. Late results of operation for primary hyperparathyroidism in 441 patients. Surgery 1986, 99: 643–51.
Kaplan EL, Yashiro T, Salti G. Primary hyperparathyroidism in the 1990s. Ann Surg 1992, 215: 300–17.
Numerow LM, Morita ET, Clark OH, Higgins CB. Persistent/recurrent hyperparathyroidism: a comparison of sestamibi scintigraphy, MRI, and ultrasonography. J Magn Reson Imaging 1995, 5: 702–8.
Shaha AR, Jaffe BM. Cervical exploration for primary hyperparathyroidism. J Surg Oncol 1993, 52: 14–7.
Clark OH, Duh QY. Primary hyperparathyroidism. A surgical perspective. Endocrinol Metab Clin North Am 1989, 18: 701–14.
Shen W, Sabanci U, Morita ET, Siperstein AE, Duh QY, Clark OH. Sestamibi scanning is inadequate for directing unilateral neck exploration for first-time parathyroidectomy. Arch Surg 1997, 132: 969–73.
Rose SM, Burns RP, Graham LD, Brock WB, Russell WL. Cost-effectiveness of preoperative localization studies in primary hyperparathyroid disease. Ann Surg 1994, 219: 582–6.
Ryan JA Jr, Eisenberg B, Pado KM, Lee F. Efficacy of selective unilateral exploration in hyperparathyroidism based on localization tests. Arch Surg 1997, 132: 886–91.
Lundgren EC, Gillott AR, Wiseman JS, Beck J. The role of preoperative localization in primary hyperparathyroidism. Am Surg 1995, 61: 393–6.
Klieger P, O’Mara R. The diagnostic utility of dual phase tc-99m sestamibi parathroid imaging. Clin Nucl Med 1998, 23: 208–11.
Reading CC, Charboneau JW, James EM, et al. High-resolution parathyroid sonography. AJR Am J Roentgenol 1982, 139: 539–46.
Ulanovski D, Feinmesser R, Cohen M, Sulkes J, Dudkiewicz M, Shpitzer T. Preoperative evaluation of patients with parathyroid adenoma role of high-resolution ultrasonography. Head Neck 2002, 24: 1–5.
Miller DL, Doppman JL, Shawker O, et al. Localization of parathyroid adenomas in patients who have undergone surgery. Noninvasive imaging methods. Radiology 1987, 162: 133–7.
Mazzeo S, Caramella D, Lencioni R, et al. Comparison among sonography, double-tracer subtraction scintigraphy, and double-phase scintigraphy in the detection of parathyroid lesions. AJR Am J Roentgenol 1996, 166: 1465–70.
Krausz Y, Lebensart PD, Klein M, et al. Preoperative localization of parathyroid adenoma in patients with concomitant thyroid nodular disease. World J Surg 2000, 24: 1573–8.
Staudenherz A, Abela C, Niederle B, et al. Comparison and histopathological correlation of three parathyroid imaging methods in a population with a high prevalence of concomitant thyroid diseases. Eur J Nucl Med 1997, 24: 143–9.
Miller DL. Pre-operative localization and interventional treatment of parathyroid tumors: when and how? World J Surg 1991, 15: 706–15.
Lumachi F, Zucchetta P, Marzola MC, et al. Advantages of combined technetium-99m-sestamibi scintigraphy and high-resolution ultrasonography in parathyroid localization: comparative study in 91 patients with primary hyperparathyroidism. Eur J Endocrinol 2000, 143: 755–60.
Gofrit ON, Lebensart PD, Pikarsky A, Lackstein D, Gross DJ, Shiloni E. High-resolution ultrasonography: highly sensitive, specific technique for preoperative localization of parathyroid adenoma in the absence of multinodular thyroid disease. World J Surg 1997, 21: 287–90.
Vogel LM, Lucas R, Czako P. Unilateral parathyroid exploration. Am Surg 1998, 64: 693–6.
Kenjiro K, Yasuaki I, Mitsumasa K, et al. Comparison of imaging methods for localization of parathyroid tumors. Am J Surg 1991, 12: 140–5.
McBiles M, Lambert AT, Cote MG, Kim SY. Sestamibi parathyroid imaging. Semin Nucl Med 1995, 25: 221–34.
Chen CC, Holder LE, Scovill WL, Tehan AM, Gann DS. Comparison of parathyroid imaging with technetium-99mpertechnetate/sestamibi subtraction, double-phase technetium-99m-sestamibi and technetium-99m-sestamibi SPECT. J Nucl Med 1997, 38: 834–9.
Sfakianakis GN, Irvin GL 3rd, Foss J, et al. Efficient parathyroidectomy guided by SPECT-MIBI and hormonal measurements. J Nucl Med 1996, 37(5): 798–804.
De Feo ML, Colagrande S, Biagini C, et al. Parathyroid glands: combination of 99m Tc- MIBI scintigraphy and US for demonstration of paratyroid glands and nodules. Radiology 2000, 214: 393–402.
McHenry CR, Lee K, Saadey J, Neumann DR, Esselstyn CB. Parathyroid localization with technetium-99m-sestamibi: a prospective evaluation. J Am Coll Surg 1996, 183: 25–30.
Caixas A, Berna L, Piera J, et al. Utility of Tc-99m-sestamibi scintigraphy as a first-line imaging procedure in the preoperative evaluation of hyperparathyroidism. Clin Endocrinol (Oxf) 1995, 43: 525–30.
Light VL, McHenry CR, Jarjura D, Sodee DB, Miron SD. Prospective evaluation of dual-phase technetium-99m-sestamibi scintigraphy and high resolution ultrasonography in the evaluation of abnormal parathyroid glands. Am Surg 1996, 62: 562–7.
Geatti O, Shapiro B, Orloson PG, et al. Localization of parathyroid enlargement: experience with technetium-99m methoxyisobutylisonitrile and thallium 201 scintigraphy, ultrasonography and computed tomography. Eur J Nucl Med 1994, 21:17–22.
Reeder SB, Desser TS, Weigel RJ, Jeffrey RB. Sonography in primary hyperparathyroidism: review with emphasis on scanning technique. J Ultrasound Med 2002, 21: 532–9.
Koslin DB, Adams J, Andersen P, Everts E, Cohen J. Preoperative evaluation of patients with primary hyperparathyroidism: role of high resolution ultrasound. Laryngoscope 1997, 107: 1249–53.
Chapuis Y, Fulla Y, Bonnichon P, et al. Values of ultrasonography, sestamibi scintigraphy, and intraoperative measurement of 1-84 PTH for unilateral neck exploration of primary hyperparathyroidism. World J Surg 1996, 20: 835–9.
Haber RS, Kim CK, Inabnet WB. Ultrasonography for preoperative localization of enlarged parathyroid glands in primary hyperparathyroidism: comparison with (99m) technetium sestamibi scintigraphy. Clin Endocrinol (Oxf) 2002, 57: 241–9.
Doppman JL, Miller DL. Localization of parathyroid tumors in patients with asymptomatic hyperparathyroidism and no previous surgery. J Bone Miner Res 1991, 6(Suppl. 2): 153–8.
Benard F, Lefebvre B, Beuvon F, Langlois MF, Bisson G. Rapid washout of technetium-99m-MIBI from a large parathyroid adenoma. J Nucl Med 1995, 36: 241–3.
Taillefer R, Boucher Y, Potvin C, Lambert R. Detection and localization of parathyroid adenomas in patients with hyperparathyroidism using a single radionuclide imaging procedure with technetium-99m-sestamibi (double phase study). J Nucl Med 1992, 33: 1801–7.
Sofferman RA, Nathan MH, Fairbank JT, Foster RS Jr, Krag DN. Preoperative technetium Tc 99m sestamibi imaging. Paving the way to minimal Access parathyroid surgery. Arch Otolaryngol Head Neck Surg 1996, 122: 369–74.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kebapci, M., Entok, E., Kebapci, N. et al. Preoperative evaluation of parathyroid lesions in patients with concomitant thyroid disease: role of high resolution ultrasonography and dual phase technetium 99m sestamibi scintigraphy. J Endocrinol Invest 27, 24–30 (2004). https://doi.org/10.1007/BF03350906
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03350906